During the past decade, Nucleo de Oncologia da Bahia conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 15 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 7 clinical trials were completed. i.e. 43.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nucleo de Oncologia da Bahia" #1 sponsor was "Janssen Research & Development, LLC" with 7 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Amgen" with 3 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nucleo de Oncologia da Bahia" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Nucleo de Oncologia da Bahia" are "Carcinoma, Non-Small-Cell Lung" (5 trials), "Breast Cancer" (4 trials), "Metastatic Breast Cancer" (4 trials), "Breast Neoplasms" (2 trials) and "Neoplasm Metastasis" (2 trials). Many other conditions were trialed in "Nucleo de Oncologia da Bahia" in a lesser frequency.

Most popular intervention types in "Nucleo de Oncologia da Bahia" are "Drug" (38 trials), "Other" (5 trials), "Biological" (4 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pemetrexed" (5 trials), "Carboplatin" (4 trials), "Docetaxel" (4 trials), "Placebo" (4 trials) and "Capecitabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Nucleo de Oncologia da Bahia" are 37 trials for "All" genders, 5 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Nucleo de Oncologia da Bahia". undefined are not yet recruiting, 12 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Nucleo de Oncologia da Bahia, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Nucleo de Oncologia da Bahia, 3 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".

Nucleo de Oncologia da Bahia has several departments that took part in Clinical trials: "Oncoclínicas Rio de Janeiro S.A." - 19 trials, "Centro Paulista de Oncologia" - 8 trials, "Multihemo" - 3 trials, "Oncocentro BH" - 3 trials